The Research of Terazosin Hydrochloride Combined with Diclofenac Sodium in Treatment of CP / CPPS
Yong Xu
Abstract
Yong Xu
Abstract
Objective:To compare terazosin monotherapy with terazosin plus diclofenac in treatment of chronic prostatitis/chronic pelvic pain syndromes(CP/CPPS) following initial randomness.Methods:Patients(n=106) who were diagnosed with CP/CPPS were randomly assigned to treatment with terazosin at 2 mg(group A),terazosin at 2 mg plus diclofenac at 25 mg(group B) daily.National Institutes of Health-Chronic Prostatitis Symptom Index(NIH-CPSI),subscores and the International Prostate Symptom Score(IPSS) were used to evaluate 104 patients who were treated for 8 weeks(2 withdrew).Results:The two groups all showed statistically difference before and after treatment,decreased in NIH-CPSI score,subscore and IPSS(P0.05).There were no statistically differences between the two groups.Conclusion:Terazosin monotherapy for 8 weeks is effective for treating patients with CP/CPPS same as with diclofenac.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To compare terazosin monotherapy with terazosin plus diclofenac in treatment of chronic prostatitis/chronic pelvic pain syndromes(CP/CPPS) following initial randomness.Methods:Patients(n=106) who were diagnosed with CP/CPPS were randomly assigned to treatment with terazosin at 2 mg(group A),terazosin at 2 mg plus diclofenac at 25 mg(group B) daily.National Institutes of Health-Chronic Prostatitis Symptom Index(NIH-CPSI),subscores and the International Prostate Symptom Score(IPSS) were used to evaluate 104 patients who were treated for 8 weeks(2 withdrew).Results:The two groups all showed statistically difference before and after treatment,decreased in NIH-CPSI score,subscore and IPSS(P0.05).There were no statistically differences between the two groups.Conclusion:Terazosin monotherapy for 8 weeks is effective for treating patients with CP/CPPS same as with diclofenac.
Key concepts: Terazosin, Medicine, Prostatitis, Diclofenac Sodium, Diclofenac, Urology, Internal medicine, Prostate